China IUCD Companies
IUCDs are a form of long-acting reversible contraception that involves placing a device inside the uterus to prevent pregnancy. These devices are often made of plastic and/or metal and can be hormonal or non-hormonal.
Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Â
Latest China IUCD Companies Update
SMB Corporation of India expands in China: In May 2023, SMB Corporation, a leading Indian manufacturer of IUDs, announced its expansion plans in China through collaboration with local distributors and medical institutions. This move strengthens SMB's presence in the Asian market and caters to the rising demand for affordable and high-quality IUDs.
Bayer launches Skyla IUD in China: In February 2023, Bayer launched its Skyla IUD, a long-acting hormonal IUD, in the Chinese market. This broader selection of IUD options with varying features and benefits increases patient choice and physician flexibility.
BGI Shenzhen unveils AI-powered screening tool for cervical cancer: In September 2023, BGI Shenzhen, a leading genomics company in China, introduced its AI-powered cervical cancer screening tool that analyzes human papillomavirus (HPV) test results, potentially contributing to earlier diagnoses and improved prevention of cervical cancer, which can be linked to IUD use.
List of China IUCD Key Companies in the Market
- SMB Corporation Of India
- Bayer HealthCare Pharmaceuticals Inc. (US)
- Mona Lisa (Belgium)
- Teva Women’s Health
- DKT International (US)
China IUCD Market Highlights:
China IUCD Market Highlights:
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
